![]() ![]() Due to this accelerated interest shown by the government to improve its healthcare infrastructure, higher opportunities may be presented especially for critical care devices as well as diagnostic imaging equipment. In addition, eight new projects are likely to be added to the existing pipeline. The recent budgets indicate £2.1billion being allocated for NHS IT upgrades and digital health technologies.Īccording to this HospeTrack Hospital Intelligence for UK, one of the major opportunities for the medical device manufacturers includes construction and expansion of 40 major hospitals across England by 2030. With respect to adoption of digital technologies within its healthcare ecosystem, UK is likely to observe higher investments in artificial intelligence, telemedicine and mobile applications. ![]() ![]() About 110 hospitals in the country provide tertiary care services while more than 500 hospitals are a part of community hospitals that provide a range of services which include community beds, maternity, and minor injury unit. United Kingdom's medical device market to be driven by proposed investments in healthcare over the next 10 years.Īs of 2021-22, UK has about 1,055 public and 278 private healthcare facilities spread throughout Great Britain and Northern Ireland. 2, 2023 /PRNewswire/ - The "HospeTrack Hospital Intelligence for United Kingdom" report has been added to The major advance of this system over current practice is that it integrates and interprets all heterogeneous data available about the patient, integrates population data where needed, and provides a consistent, repeatable, quantitative and auditable record of the information that contributes to the decision process.ĭUBLIN, Feb. The target user of this Decision Support System is the healthcare professional, in this case the surgeon or cardiologist, who will make the decision on the nature and timing of the intervention. DSS may have major impact on patients with borderline indications for treatment (valve replacement/repair), complex hemodynamic conditions such as combined aortic-mitral valve disease and valve geometries that are subject to valve repair. In addition the DSS will improve knowledge of disease mechanisms by applying a holistic assessment of cardiovascular function that includes hemodynamic data at all cardiovascular compartments (ventricle, valve, vessels) and multiscale components that couple organ with cell function. By combining multiple complex modelling components, a comprehensive, clinically-compliant decision-support system will be developed to meet this challenge, by quantifying individualised disease severity and patient impairment, predicting disease progression, ranking the effectiveness of alternative candidate procedures, and optimising the patient-specific intervention plan. It is dominated by two conditions, Aortic Stenosis and Mitral Regurgitation, both of which are associated with significant morbidity and mortality, yet which pose a truly demanding challenge for treatment optimisation. Valvular Heart Disease currently affects 2.5% of the population, but is overwhelmingly a disease of the elderly and consequently on the rise. ![]()
0 Comments
Leave a Reply. |